Skip to content
★ Sign in to follow
JB

Jinyu Bio-technology Co., Ltd. Stock: price and insider trades · China

生物股份

CN·Mcap CN¥13.5BHealth Care

No insider purchase over the last 90 days. The latest, by 张翀宇, was filed 22 Apr 2022.

Jinyu Bio-technology Co., Ltd.: what insiders have been doing

Jinyu Bio-technology Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). No insider at Jinyu Bio-technology Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 22 April 2022.

Over the whole record (from 2022), the tally stands at 2 purchases and no sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€8M
2 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 22 Apr 2022 · 1663 days ago · €3.1M
    +23.2%
    Entry CN¥8.36 · Close at T+365 CN¥10.30
  • Filed 22 Apr 2022 · 1663 days ago · €4.8M
    +23.2%
    Entry CN¥8.36 · Close at T+365 CN¥10.30

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,646 of 26,911 companies
48.9
score / 100
Value
30
Quality
68
FCF yld1.4%
Earn yld0.7%
EV/EBITDA37.0x
ROE2.7%
Gross mgn54%
Net mgn7.2%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥12.23
Analyst consensus
3 analysts
1.00/5
CN¥7.98Target CN¥12.33(+1%)CN¥15.00
Income statement
RevenueCN¥1.4B
Gross profitCN¥747.5M54% margin
EBITDACN¥363.9M26% margin
Net incomeCN¥100.1M9.4% margin
Valuation
PER (trailing)94.1x
P/Book2.5x
Beta0.67
Balance sheet & cash
Market capCN¥13.5B
Total debtCN¥1.6M
Free Cash FlowCN¥194.7M
Debt / Equity2%
Profitability & ownership
ROE2.7%
ROA0.6%
% insiders21.5%
% institutions8.9%
Last declaration on 22 April 2022
Declarations2 total
  • ▲
    董事Executives
    22M CNY27SSE
    2,400,000 shares100.0% of flowA股XSHGSSE:173000005464359360
    Canonical exit: 21 Jul 2022 (T+90)
  • ▲
    董事,高级管理人员Executives
    34M CNY27SSE
    3,737,942 shares100.0% of flowA股XSHGSSE:173000005464359300
    Canonical exit: 21 Jul 2022 (T+90)

2 of 2 declarations

About Jinyu Bio-technology Co., Ltd.

生物股份 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of biopharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations